theria toxoid (PRP-D); 6 were imnunized with PRP conjugated to outer membrane protein of M menin itidis Each serum was used to passively immunize a serie-kats, followed by subcutaneous inoculation of virulent Hlb, The dose of total PRP Ab (Farr technique) required to prevent bacteremia and/or meningitis in 50% of rats (PD50) ranged from 13-916 ng/rat. Sera were also tested for in vitro opsonic activity. Neither protection nor ppsonic activity correlated with total PRP Ab. Analysis of anti-PRP IgG, IgG subclass and IgM Ab suggested that high IgG and IgM Ab were associated with protectipn. A drop in protection was associated with low Ab of two or more IgG subclasses. No single subclass response was consistently protective. High levels of 1964 and IgM Ab were present in the most opsonic and protective sera. Anti-PRP IgM alone did not compensate for low levels of two or more IgG subclass Ab's. Full protection probably cannot be realized when there are low levels of Ab of 2 or more of the heavy chain genotypes tested ( IgM, IgG1-4). Table) . The G2D subjects had significantly lower IgGl responses (measured by ELISA) than CON (P=.003) and, as expected, the G2D patients also had lower IgGZ responses (P<.001). 11/16 G2D patients (mean age=56 mo) have been vaccinated with PN PS vaccine. The IgG responses to P-3 and P-23 were lower than those of 17 vaccinated CON children (mean age=49 mo), (P<.03 and .09, respectively). Thus, G2D patients have deficient IgG antibody responses to Hib, and P-3 and P-23 PN PS. However, this deficiency is not necessarily related directly to low serum concentrations of IgG2 since G2D patients have deficient IgGl responses to Hib PS des~ite normal serum InGI. Human CD4 inducer T lymphocytes consist of two functionally distinct subpopulations. The monoclonal antibody anti-2H4 identifies CD4 cells that induce T suppressor cell function and proliferate in the AMLR, while the monoclonal antibody anti-4B4 identifies CD4 cells that primarily induce B cell help. To define the ontogeny of these inducer subpopulations we studied their number and functional capabilities in seven patients following allogeneic and autologous bone marrow transplantation (BMTx). During the first 90 days following BMTx, both the helperlinducer CD4+ 4B4+ and suppressor/inducer CD4+ 2H4+ subpopul&tions were elevated (BMTx CD4+ 4B4+ = 75+3% versus control = 42+3%; BMTx CD4+ 2H4+ = 77+5% versus control-= 43+2%). However, theFe was a paradoxical defyciency in the functionof the two subpopulations. BMTx patients had a depressed AMLR stimulation index of 3.2+0.5% of control. Hunan CD4+ inducer T lymphocytes consist of heterogeneous populations that can be defined either by the monoclonal antibody anti-2H4, which identifies CD4+ cells capable of inducing suppressor T cell function, or by anti-4B4, which identifies CD4+ cells that induce T cell help for B cells. To determine if these subpopulations are terminally differentiated cells within the CD4 lineage, or if they can be modulated by various stimuli, we examined the number and function of the CD4+2H4+ and CD4+4B4+ subpopulations before and after mitogenic activation. Stimulation of CD4+ cells with 10 mcglml Concanavalin A (Con A) selectively increased the percentage of cells expressing the CD4+2H4+ phenotype from 4 3 5 % to 82+4%. No change occurred in CD4+4B4+ cells (41~2% to 4054%). ~i T o m~c i n C treatment prior to Con A stimulation abrogated the increase in CD4+2H4+ expression. In contrast to Con A, PHA stimulation produced a non-selective increase in both 2H4 (96%) and 4B4 (92%) expression. Functional studies using autologous T plus B cells in pokeweed driven cocultures, revealed that the Con A activated CD4+ cells induced a T-cell mediated suppression (80~4%) of IgG synthesis. Thus, Con A selectively expands the 2H4+ subpopulation within the CD4+ subset of T cells. The CD4+2H4+ subpopulation may represent a functionally distinct, terminally differentiated suppressor/inducer cell.
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